Frequency of Symptomatic and Asymptomatic Herpes Simplex Virus Type 2 Reactivations among Human Immunodeficiency Virus—Infected Men

Herpes simplex virus (HSV) infection is common in persons coinfected with human immunodeficiency virus (HIV). In a prospective study, daily viral cultures of the mouth, genitals, and rectum were collected from 68 HIV-positive and 13 HIV-negative men who have sex with men. Subjects completed a median...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 178; no. 6; pp. 1616 - 1622
Main Authors Schacker, Timothy, Zeh, Judith, Hu, Hui-lin, Hill, Edgar, Corey, Lawrence
Format Journal Article
LanguageEnglish
Published Chicago, IL University Chicago Press 01.12.1998
University of Chicago Press
Oxford University Press
Subjects
Online AccessGet full text
ISSN0022-1899
1537-6613
1537-6613
DOI10.1086/314486

Cover

Abstract Herpes simplex virus (HSV) infection is common in persons coinfected with human immunodeficiency virus (HIV). In a prospective study, daily viral cultures of the mouth, genitals, and rectum were collected from 68 HIV-positive and 13 HIV-negative men who have sex with men. Subjects completed a median of 57 days of follow-up. Anogenital HSV-2 cultures were positive on 405 (9.7%) of 4167 days for HIV-positive men and on 24 (3.1%) of 766 days for HIV-negative men. Most reactivations were perirectal and subclinical. Risk factors for increased HSV-2 shedding among HIV-positive men were low CD4 cell count (odds ratio, 2.5; 95% confidence interval, 1.2–5.4) and antibodies to both HSV-1 and HSV-2 versus HSV-2 only (odds ratio, 1.9; 95% confidence interval, 1.0–3.7). Three isolates obtained from 3 separate subjects were resistant to acyclovir. Thus, subclinical HSV-2 reactivation is an important opportunistic infection in persons with HIV infection. Further studies are necessary to determine the impact of subclinical HSV-2 reactivation on the natural history of HIV infection.
AbstractList Herpes simplex virus (HSV) infection is common in persons coinfected with human immunodeficiency virus (HIV). In a prospective study, daily viral cultures of the mouth, genitals, and rectum were collected from 68 HIV-positive and 13 HIV-negative men who have sex with men. Subjects completed a median of 57 days of follow-up. Anogenital HSV-2 cultures were positive on 405 (9.7%) of 4167 days for HIV-positive men and on 24 (3.1%) of 766 days for HIV-negative men. Most reactivations were perirectal and subclinical. Risk factors for increased HSV-2 shedding among HIV-positive men were low CD4 cell count (odds ratio, 2.5; 95% confidence interval, 1.2-5.4) and antibodies to both HSV-1 and HSV-2 versus HSV-2 only (odds ratio, 1.9; 95% confidence interval, 1.0-3.7). Three isolates obtained from 3 separate subjects were resistant to acyclovir. Thus, subclinical HSV-2 reactivation is an important opportunistic infection in persons with HIV infection. Further studies are necessaryto determine the impact of subclinical HSV-2 reactivation on the natural history of HIV infection.
Herpes simplex virus (HSV) infection is common in persons coinfected with human immunodeficiency virus (HIV). In a prospective study, daily viral cultures of the mouth, genitals, and rectum were collected from 68 HIV-positive and 13 HIV-negative men who have sex with men. Subjects completed a median of 57 days of follow-up. Anogenital HSV-2 cultures were positive on 405 (9.7%) of 4167 days for HIV-positive men and on 24 (3.1%) of 766 days for HIV-negative men. Most reactivations were perirectal and subclinical. Risk factors for increased HSV-2 shedding among HIV-positive men were low CD4 cell count (odds ratio, 2.5; 95% confidence interval, 1.2-5.4) and antibodies to both HSV-1 and HSV-2 versus HSV-2 only (odds ratio, 1.9; 95% confidence interval, 1.0-3.7). Three isolates obtained from 3 separate subjects were resistant to acyclovir. Thus, subclinical HSV-2 reactivation is an important opportunistic infection in persons with HIV infection. Further studies are necessary to determine the impact of subclinical HSV-2 reactivation on the natural history of HIV infection.
Herpes simplex virus (HSV) infection is common in persons coinfected with human immunodeficiency virus (HIV). In a prospective study, daily viral cultures of the mouth, genitals, and rectum were collected from 68 HIV-positive and 13 HIV-negative men who have sex with men. Subjects completed a median of 57 days of follow-up. Anogenital HSV-2 cultures were positive on 405 (9.7%) of 4167 days for HIV-positive men and on 24 (3.1%) of 766 days for HIV-negative men. Most reactivations were perirectal and subclinical. Risk factors for increased HSV-2 shedding among HIV-positive men were low CD4 cell count (odds ratio, 2.5; 95% confidence interval, 1.2-5.4) and antibodies to both HSV-1 and HSV-2 versus HSV-2 only (odds ratio, 1.9; 95% confidence interval, 1.0-3.7). Three isolates obtained from 3 separate subjects were resistant to acyclovir. Thus, subclinical HSV-2 reactivation is an important opportunistic infection in persons with HIV infection. Further studies are necessaryto determine the impact of subclinical HSV-2 reactivation on the natural history of HIV infection.Herpes simplex virus (HSV) infection is common in persons coinfected with human immunodeficiency virus (HIV). In a prospective study, daily viral cultures of the mouth, genitals, and rectum were collected from 68 HIV-positive and 13 HIV-negative men who have sex with men. Subjects completed a median of 57 days of follow-up. Anogenital HSV-2 cultures were positive on 405 (9.7%) of 4167 days for HIV-positive men and on 24 (3.1%) of 766 days for HIV-negative men. Most reactivations were perirectal and subclinical. Risk factors for increased HSV-2 shedding among HIV-positive men were low CD4 cell count (odds ratio, 2.5; 95% confidence interval, 1.2-5.4) and antibodies to both HSV-1 and HSV-2 versus HSV-2 only (odds ratio, 1.9; 95% confidence interval, 1.0-3.7). Three isolates obtained from 3 separate subjects were resistant to acyclovir. Thus, subclinical HSV-2 reactivation is an important opportunistic infection in persons with HIV infection. Further studies are necessaryto determine the impact of subclinical HSV-2 reactivation on the natural history of HIV infection.
Author Corey, Lawrence
Zeh, Judith
Schacker, Timothy
Hill, Edgar
Hu, Hui-lin
Author_xml – sequence: 1
  givenname: Timothy
  surname: Schacker
  fullname: Schacker, Timothy
  email: schac008@Lenti.med.umn.edu
  organization: Department of Medicine, University of Minnesota, Minneapolis, Seattle, Washington, Chapel Hill, North Carolina
– sequence: 2
  givenname: Judith
  surname: Zeh
  fullname: Zeh, Judith
  organization: Department of Medicine, University of Minnesota, Minneapolis, Seattle, Washington, Chapel Hill, North Carolina
– sequence: 3
  givenname: Hui-lin
  surname: Hu
  fullname: Hu, Hui-lin
  organization: Department of Medicine, University of Minnesota, Minneapolis, Seattle, Washington, Chapel Hill, North Carolina
– sequence: 4
  givenname: Edgar
  surname: Hill
  fullname: Hill, Edgar
  organization: Department of Medicine, University of Minnesota, Minneapolis, Seattle, Washington, Chapel Hill, North Carolina
– sequence: 5
  givenname: Lawrence
  surname: Corey
  fullname: Corey, Lawrence
  organization: Department of Medicine, University of Minnesota, Minneapolis, Seattle, Washington, Chapel Hill, North Carolina
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1618050$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/9815213$$D View this record in MEDLINE/PubMed
BookMark eNp1kc1u1DAUhS1UVKYDvAGShRBsCPgvTrKsKtoZqYDEDKhiY3mcG-QhsYOdQLNjwxvwhDwJ6Uw0oCJWlnw-33t8zgk6ct4BQg8peUFJLl9yKkQu76AZTXmWSEn5EZoRwlhC86K4h05i3BJCBJfZMToucpoyymfox3mALz04M2Bf4dXQtJ1vdGcN1q7Ep_GviwWEFiJe2aat4Rp_sKGPeD20gBl-B9p09uvIeRexbrz7hBd9ox1eNk3vfAmVNXa3Zvfu1_efS1eB6aDEr8HdR3crXUd4MJ1z9P781fpskVy-vVienV4mRjDWJcZsaFWAzozIqdAlZQVl2QagkJkpC5lSIrQoyUaAFFXGaG42qSgrw_gIVSmfo2f7ub1r9fBN17Vqg210GBQl6iZHtc9xJJ_uyTb4MZ_YqcZGA3WtHfg-qowQSdKUjODjW-DW98GNv1CM8YIUfKxijh5NUL9poDwsnWoY9SeTrqPRdRW0Mzb-8SZpTna7JlMm-BgDVP93__wWaGy3K6cL2tb_4pO9bex8OAzlhFIq5I29ZK_b2MH1Qdfhs5IZz1K1uPqoVm_WaZqxC3XFfwP8w8tg
CODEN JIDIAQ
CitedBy_id crossref_primary_10_1086_422364
crossref_primary_10_1128_JCM_40_7_2609_2611_2002
crossref_primary_10_1172_JCI57148
crossref_primary_10_1016_j_jaad_2007_06_027
crossref_primary_10_1016_j_vaccine_2016_09_001
crossref_primary_10_1080_21505594_2021_1982373
crossref_primary_10_1172_JCI60556
crossref_primary_10_1371_journal_pone_0002230
crossref_primary_10_1016_j_gofs_2017_10_003
crossref_primary_10_1111_j_1542_2011_2012_00179_x
crossref_primary_10_1086_313647
crossref_primary_10_3109_10428194_2012_755178
crossref_primary_10_1007_s11908_000_0084_y
crossref_primary_10_1097_00007435_200204000_00008
crossref_primary_10_1086_422361
crossref_primary_10_1097_00126334_200209010_00012
crossref_primary_10_1128_JVI_01089_15
crossref_primary_10_1097_OLQ_0b013e31821a5d2c
crossref_primary_10_1586_eri_09_21
crossref_primary_10_1097_00007435_200302000_00004
crossref_primary_10_1016_j_vaccine_2012_08_049
crossref_primary_10_1093_cid_civ908
crossref_primary_10_1097_00007435_200008000_00001
crossref_primary_10_1159_000049521
crossref_primary_10_1007_BF03256439
crossref_primary_10_1016_j_it_2012_04_002
crossref_primary_10_1038_gene_2016_42
crossref_primary_10_1086_589621
crossref_primary_10_1016_S0213_9251_03_72778_6
crossref_primary_10_1038_mi_2009_23
crossref_primary_10_1093_infdis_jiv451
crossref_primary_10_1177_09564624241282396
crossref_primary_10_1002__SICI_1098_0997_2000_8_1_3__AID_IDOG2_3_0_CO_2_2
crossref_primary_10_1016_j_det_2006_06_010
crossref_primary_10_1097_00007435_200001000_00006
crossref_primary_10_1128_AAC_01072_12
crossref_primary_10_1016_j_jogc_2017_04_027
crossref_primary_10_1056_NEJM200003233421203
crossref_primary_10_3390_biology13121050
crossref_primary_10_1093_infdis_jir766
crossref_primary_10_1097_OLQ_0b013e3181812d15
crossref_primary_10_1097_QAI_0b013e3181d91322
crossref_primary_10_1016_S1201_9712_02_90157_8
crossref_primary_10_1097_OLQ_0000000000001578
crossref_primary_10_1371_journal_pone_0114989
crossref_primary_10_1086_505496
crossref_primary_10_1097_OLQ_0b013e31818d3fb6
crossref_primary_10_1111_j_1365_2567_2009_03170_x
crossref_primary_10_1517_14656566_7_6_665
crossref_primary_10_1182_blood_2012_03_418624
crossref_primary_10_1016_j_chom_2009_10_010
crossref_primary_10_1086_590112
crossref_primary_10_1093_infdis_jir260
crossref_primary_10_1128_JVI_01721_18
crossref_primary_10_3389_fimmu_2020_598884
crossref_primary_10_1097_00007435_200110000_00005
crossref_primary_10_1136_bmjgh_2019_001875
crossref_primary_10_1258_ijsa_2009_008477
crossref_primary_10_1086_342104
crossref_primary_10_1586_14787210_5_2_231
crossref_primary_10_1111_aji_12133
crossref_primary_10_1086_499356
crossref_primary_10_1310_AQML_UABK_5LLB_E615
crossref_primary_10_1080_02664763_2015_1022138
crossref_primary_10_1002_jmv_23634
crossref_primary_10_1177_0956462415580512
crossref_primary_10_1016_S1473_3099_17_30405_X
crossref_primary_10_1371_journal_pone_0147422
crossref_primary_10_1097_OLQ_0000000000000022
crossref_primary_10_1097_OLQ_0b013e318239d7fd
crossref_primary_10_1056_NEJMoa0800260
crossref_primary_10_1086_342971
crossref_primary_10_1172_jci_insight_88529
crossref_primary_10_1016_j_vaccine_2017_09_044
crossref_primary_10_1086_342969
crossref_primary_10_1097_00001432_200406000_00005
crossref_primary_10_1086_425274
crossref_primary_10_1128_JVI_74_14_6680_6683_2000
crossref_primary_10_1007_s11538_008_9379_1
crossref_primary_10_1016_j_jcv_2004_09_022
crossref_primary_10_1086_425272
crossref_primary_10_1128_JVI_02745_12
crossref_primary_10_1007_s11908_012_0241_0
crossref_primary_10_1007_s11908_007_0077_1
crossref_primary_10_1128_JCM_01405_06
crossref_primary_10_1007_s11908_000_0093_x
crossref_primary_10_1136_bmjopen_2013_004210
crossref_primary_10_1093_infdis_jit333
crossref_primary_10_14745_ccdr_v42i02a03
crossref_primary_10_1016_j_vaccine_2008_11_074
crossref_primary_10_1002_jmv_24061
crossref_primary_10_1002_rmv_424
crossref_primary_10_1007_s13365_015_0348_9
crossref_primary_10_1016_S2214_109X_16_30362_X
crossref_primary_10_1097_OLQ_0b013e31823fadf3
crossref_primary_10_1177_0956462415577727
crossref_primary_10_3390_v16050673
crossref_primary_10_25208_vdv7753
crossref_primary_10_1097_00007435_200102000_00007
crossref_primary_10_1099_vir_0_18808_0
crossref_primary_10_1093_aje_kwj270
crossref_primary_10_1016_S1701_2163_16_32806_7
crossref_primary_10_1155_2011_157680
crossref_primary_10_1097_00002030_200006160_00019
crossref_primary_10_1099_vir_0_79978_0
crossref_primary_10_1097_00007435_200108000_00001
crossref_primary_10_1086_427906
crossref_primary_10_1016_S0733_8635_01_00003_1
crossref_primary_10_1002_dc_23006
crossref_primary_10_1016_j_vaccine_2018_02_067
crossref_primary_10_1146_annurev_med_59_061606_095540
crossref_primary_10_1007_s11894_008_0078_8
crossref_primary_10_1097_QAD_0b013e32831c5497
crossref_primary_10_3390_life14050596
crossref_primary_10_1517_17425247_2012_668183
crossref_primary_10_1097_00126334_200404150_00001
crossref_primary_10_1177_0956462414546504
crossref_primary_10_1097_00007435_200307000_00011
crossref_primary_10_1097_OLQ_0b013e318244ac4c
crossref_primary_10_1016_j_jogc_2017_04_015
crossref_primary_10_1007_s00105_007_1443_5
crossref_primary_10_1016_j_clindermatol_2023_12_005
crossref_primary_10_1517_14656566_7_16_2271
crossref_primary_10_1086_322654
crossref_primary_10_1086_318722
crossref_primary_10_1097_00002030_200108004_00011
crossref_primary_10_1016_S0140_6736_07_61908_4
crossref_primary_10_1002_14651858_CD006492_pub2
crossref_primary_10_1086_426438
crossref_primary_10_1128_JVI_01374_09
crossref_primary_10_1097_QCO_0b013e3282f3d9d3
crossref_primary_10_1371_journal_pone_0155124
crossref_primary_10_1016_S0166_3542_99_00052_2
crossref_primary_10_1016_S1701_2163_16_32805_5
crossref_primary_10_1128_JVI_02521_10
crossref_primary_10_1097_GRF_0b013e3182718e0d
crossref_primary_10_1097_00002030_200202150_00018
crossref_primary_10_1097_00002030_200212060_00007
crossref_primary_10_1111_j_1468_1293_2011_00944_7_x
crossref_primary_10_1016_S0140_6736_06_69482_8
crossref_primary_10_1097_00002030_200105040_00009
crossref_primary_10_1016_j_idc_2005_04_005
crossref_primary_10_1186_s12981_022_00469_w
ContentType Journal Article
Copyright Copyright 1998 Infectious Diseases Society of America
1999 INIST-CNRS
Copyright University of Chicago, acting through its Press Dec 1998
Copyright_xml – notice: Copyright 1998 Infectious Diseases Society of America
– notice: 1999 INIST-CNRS
– notice: Copyright University of Chicago, acting through its Press Dec 1998
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
K9.
NAPCQ
7X8
ADTOC
UNPAY
DOI 10.1086/314486
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitleList MEDLINE

ProQuest Health & Medical Complete (Alumni)

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1537-6613
EndPage 1622
ExternalDocumentID 10.1086/314486
37672273
9815213
1618050
10_1086_314486
30111463
ark_67375_HXZ_SNT5572G_X
Genre Research Support, U.S. Gov't, P.H.S
Journal Article
GeographicLocations United States
North America
Washington
America
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: AI01338
– fundername: NIAID NIH HHS
  grantid: AI-27664
– fundername: NIAID NIH HHS
  grantid: AI-30731
GroupedDBID ---
-DZ
-~X
..I
.2P
.55
.GJ
.I3
.XZ
.ZR
08P
0R~
123
1KJ
1TH
29K
2AX
2WC
36B
3O-
4.4
41~
48X
53G
5GY
5RE
5VS
5WD
70D
85S
AABZA
AACGO
AACZT
AAFWJ
AAHBH
AAHTB
AAJKP
AAJQQ
AAMVS
AANCE
AAOGV
AAPGJ
AAPNW
AAPQZ
AAPXW
AAQQT
AARHZ
AAUAY
AAUQX
AAVAP
AAWDT
AAWTL
ABBHK
ABDFA
ABDPE
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABLJU
ABNHQ
ABNKS
ABOCM
ABPEJ
ABPLY
ABPPZ
ABPQP
ABPTD
ABQLI
ABQNK
ABSMQ
ABTLG
ABVGC
ABWST
ABXSQ
ABXVV
ABZBJ
ACFRR
ACGFO
ACGFS
ACGOD
ACHIC
ACPQN
ACPRK
ACUFI
ACUTJ
ACUTO
ACVCV
ACYHN
ACZBC
ADBBV
ADEYI
ADGZP
ADHKW
ADHZD
ADIPN
ADMTO
ADNBA
ADOCK
ADQBN
ADQXQ
ADRTK
ADULT
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKPW
AEKSI
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEUPB
AEWNT
AEXZC
AFFNX
AFFQV
AFFZL
AFHKK
AFIYH
AFOFC
AFQQW
AFSHK
AFXAL
AFYAG
AGINJ
AGKEF
AGKRT
AGMDO
AGORE
AGQXC
AGSYK
AGUTN
AHGBF
AHMBA
AHMMS
AHXPO
AI.
AIAGR
AIJHB
AJBYB
AJDVS
AJEEA
AJNCP
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APJGH
APWMN
AQDSO
AQKUS
AQVQM
ATGXG
AVNTJ
AXUDD
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BR6
BSCLL
BTRTY
BVRKM
BZKNY
C45
CDBKE
CS3
CZ4
D-I
DAKXR
DCCCD
DIK
DILTD
DU5
D~K
EBS
ECGQY
EE~
EIHJH
EJD
EMOBN
ENERS
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HQ3
HTVGU
HW0
HZ~
IH2
IOX
IPSME
J21
J5H
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JST
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
LSO
LU7
MBLQV
MHKGH
MJL
ML0
MVM
N4W
N9A
NEJ
NGC
NOMLY
NOYVH
NU-
NVLIB
O0~
O9-
OAUYM
OAWHX
OBFPC
OCZFY
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
O~Y
P0-
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
QBD
RD5
ROX
ROZ
RUSNO
RW1
RXO
SA0
SJN
TCURE
TEORI
TJX
TMA
TR2
VH1
W2D
W8F
WH7
X7H
X7M
Y6R
YAYTL
YKOAZ
YXANX
ZE2
ZGI
ZXP
~91
AAYXX
CITATION
IQODW
6.Y
AAYOK
ABSAR
ADJQC
ADRIX
AFXEN
CGR
CUY
CVF
DOOOF
ECM
EIF
ESX
JSODD
M49
NPM
VXZ
YIF
ZKG
K9.
NAPCQ
7X8
ADTOC
UNPAY
ID FETCH-LOGICAL-c422t-ccb1f9ea7c4814ad129127bee967cd965104a4d0b4e64f7218cb54dfc23beef53
IEDL.DBID UNPAY
ISSN 0022-1899
1537-6613
IngestDate Tue Aug 19 09:38:01 EDT 2025
Sat Sep 27 19:09:40 EDT 2025
Mon Oct 06 18:13:44 EDT 2025
Wed Feb 19 02:36:03 EST 2025
Mon Jul 21 09:13:49 EDT 2025
Thu Apr 24 22:55:42 EDT 2025
Wed Oct 01 04:03:38 EDT 2025
Fri Jun 20 02:31:39 EDT 2025
Sat Sep 20 11:01:50 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Human
Immunopathology
Opportunistic infection
Reactivation
Prevalence
Herpesviridae
Alphaherpesvirinae
Herpes
Male
AIDS
Serology
Immune deficiency
Epidemiology
Infection
Virus
Symptomatology
Herpesvirus hominis 2
Viral disease
Male genital diseases
Anorectal disease
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c422t-ccb1f9ea7c4814ad129127bee967cd965104a4d0b4e64f7218cb54dfc23beef53
Notes Reprints: Dr. Larry Corey, Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, 1124 Columbia St., M-115, Seattle, WA 98104.
istex:46ACBB3269CD4D6CB40057621AE0EF121BF31095
ark:/67375/HXZ-SNT5572G-X
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://proxy.k.utb.cz/login?url=https://academic.oup.com/jid/article-pdf/178/6/1616/17991410/178-6-1616.pdf
PMID 9815213
PQID 223909361
PQPubID 41591
PageCount 7
ParticipantIDs unpaywall_primary_10_1086_314486
proquest_miscellaneous_70060550
proquest_journals_223909361
pubmed_primary_9815213
pascalfrancis_primary_1618050
crossref_primary_10_1086_314486
crossref_citationtrail_10_1086_314486
jstor_primary_30111463
istex_primary_ark_67375_HXZ_SNT5572G_X
ProviderPackageCode CITATION
AAYXX
PublicationCentury 1900
PublicationDate 1998-12-01
PublicationDateYYYYMMDD 1998-12-01
PublicationDate_xml – month: 12
  year: 1998
  text: 1998-12-01
  day: 01
PublicationDecade 1990
PublicationPlace Chicago, IL
PublicationPlace_xml – name: Chicago, IL
– name: United States
– name: Oxford
PublicationTitle The Journal of infectious diseases
PublicationTitleAlternate The Journal of Infectious Diseases
PublicationYear 1998
Publisher University Chicago Press
University of Chicago Press
Oxford University Press
Publisher_xml – name: University Chicago Press
– name: University of Chicago Press
– name: Oxford University Press
SSID ssj0004367
Score 2.063883
Snippet Herpes simplex virus (HSV) infection is common in persons coinfected with human immunodeficiency virus (HIV). In a prospective study, daily viral cultures of...
SourceID unpaywall
proquest
pubmed
pascalfrancis
crossref
jstor
istex
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1616
SubjectTerms Acyclovir - therapeutic use
Adult
Aged
Anatomy
Antibodies, Viral - blood
Antiviral Agents - therapeutic use
Biological and medical sciences
CD4 Lymphocyte Count
Confidence Intervals
Epidemiology
Follow-Up Studies
Fundamental and applied biological sciences. Psychology
Genitalia
Genitalia, Male - virology
Herpes Genitalis - complications
Herpes Genitalis - epidemiology
Herpes Genitalis - immunology
Herpesvirus 1, Human - immunology
Herpesvirus 2, Human - growth & development
Herpesvirus 2, Human - immunology
Herpesvirus 2, Human - isolation & purification
HIV
HIV 1
HIV Infections - complications
HIV Infections - immunology
HIV Seronegativity - immunology
Homosexuality, Male
Human herpesvirus 1
Human herpesvirus 2
Human viral diseases
Humans
Infections
Infectious diseases
Lesions
Major Article
Male
Medical sciences
Microbiology
Middle Aged
Mouth - virology
Odds Ratio
Rectum - virology
Recurrence
Risk Factors
Simplexvirus
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
Virology
Virus Activation
Virus Shedding
Viruses
Title Frequency of Symptomatic and Asymptomatic Herpes Simplex Virus Type 2 Reactivations among Human Immunodeficiency Virus—Infected Men
URI https://api.istex.fr/ark:/67375/HXZ-SNT5572G-X/fulltext.pdf
https://www.jstor.org/stable/30111463
https://www.ncbi.nlm.nih.gov/pubmed/9815213
https://www.proquest.com/docview/223909361
https://www.proquest.com/docview/70060550
https://academic.oup.com/jid/article-pdf/178/6/1616/17991410/178-6-1616.pdf
UnpaywallVersion publishedVersion
Volume 178
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1537-6613
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0004367
  issn: 1537-6613
  databaseCode: KQ8
  dateStart: 19970401
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1537-6613
  dateEnd: 20241101
  omitProxy: true
  ssIdentifier: ssj0004367
  issn: 1537-6613
  databaseCode: DIK
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1537-6613
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0004367
  issn: 1537-6613
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbYVrwOPBYqyrKLD8AtbZw4dnKsEN0uUleIblHhEjmJLS1b0qppxZYTF34B_5BfwozzoLzEhUsOzjiOnbHnczwzHyFPXJYyro10UmmUwzEGOGRGOz5aC4lbCPszZ3wqRlP-chbMKjogjIVRlVd4rw5peA_fpBpEZ5mZPpNhX_QBp8BFArjhzMUyRzhY1gORPdIWAQDzFmlPT18N3tb5wllo2SRhiksHrJK_wzTkw7YCo6l3TFMbR_my9lJEl0lVwKiZku7iT3j0Jrm-yZdq-1HN5zs2anibzOvela4pF73NOumln35J_Pifun-H3KqwLB2UFe-SKzrfJ1dLdsvtPrk2rs7t75Evw1Xpsr2lC0Mn2w_L9cLmiqUqz-ig2CkY6dVSF3RyjmmLL-mb89WmoLhbph59rTEMo_yJXFDLk0TtKQQ9wTCXRaYxH4Ztxtb79vnriXU20xkd6_w-mQ5fnD0fORUBhJNyz1s7aZowE2klUx4yrjLAJsyTidaRkGkWCVhPuOKZm3AtuIG9bJgmAc9M6vkgZAK_Q1r5ItcPCPUTz0uEzHyuoI7Socmkz-DJJkLGLr9LntbfPk6r7OhI0jGP7Sl9KOJSR7rkcSO3LPOB_CbxzKpOc1utLtB7TgbxaPYunpyeBTAJjuNZl3SsbjWCuNaC4YJ3OfxJ2X40JFjoBm6XHNTKF1crThEDzIvcyBcM3rC5C0sFnv-oXC82RSwx-U6A9TulxjYPjkKEcdAwbTT4L717-G-RA3LDBm5an59HpLVebfQhILd1ckT2jmfsqJqX3wGoPDyl
linkProvider Unpaywall
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELagFa8Dj10qyrLgA3BLGyeOnRwrROkitUJ0iwqXyElsadmSVk0rtpy48Av4h_wSZpwH5SUuXHJwxnHsjD2f45n5CHnsspRxbaSTSqMcjjHAITPa8dFaSNxC2J8544kYzfjLeTCv6IAwFkZVXuG9OqThPXyTahCdVWb6TIZ90QecAhcJ4IYzF8sc4WBZD0Quk7YIAJi3SHs2eTV4W-cLZ6Flk4QpLh2wSv4e05AP2wqMpt4zTW0c5YvaSxFdJlUBo2ZKuos_4dEb5No2X6ndR7VY7Nmo4S2yqHtXuqac97abpJd--iXx43_q_m1ys8KydFBWvEMu6fyAXCnZLXcH5Oq4Orc_JF-G69Jle0eXhk53H1abpc0VS1We0UGxVzDS65Uu6PQM0xZf0Ddn621BcbdMPfpaYxhG-RO5oJYnidpTCHqCYS7LTGM-DNuMrfft89cT62ymMzrW-V0yGz4_fTZyKgIIJ-Wet3HSNGEm0kqmPGRcZYBNmCcTrSMh0ywSsJ5wxTM34VpwA3vZME0CnpnU80HIBH6HtPJlru8R6ieelwiZ-VxBHaVDk0mfwZNNhIxdfpc8qb99nFbZ0ZGkYxHbU_pQxKWOdMmjRm5V5gP5TeKpVZ3mtlqfo_ecDOLR_F08nZwGMAlexPMu6VjdagRxrQXDBe9y_JOy_WhIsNAN3C45qpUvrlacIgaYF7mRLxi8YXMXlgo8_1G5Xm6LWGLynQDrd0qNbR4chQjjoGHaaPBfenf_3yJH5LoN3LQ-Pw9Ia7Pe6mNAbpvkYTUjvwNCFzu0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Frequency+of+Symptomatic+and+Asymptomatic+Herpes+Simplex+Virus+Type+2+Reactivations+among+Human+Immunodeficiency+Virus%E2%80%93Infected+Men&rft.jtitle=The+Journal+of+infectious+diseases&rft.au=Schacker%2C+Timothy&rft.au=Zeh%2C+Judith&rft.au=Hu%2C+Hui%E2%80%90lin&rft.au=Hill%2C+Edgar&rft.date=1998-12-01&rft.issn=0022-1899&rft.eissn=1537-6613&rft.volume=178&rft.issue=6&rft.spage=1616&rft.epage=1622&rft_id=info:doi/10.1086%2F314486&rft.externalDBID=n%2Fa&rft.externalDocID=10_1086_314486
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1899&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1899&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1899&client=summon